NATCO News | NATCO

Current Status of Kidney Xenotransplantation in Basic Research

End-stage kidney disease is a major global health issue, with kidney transplantation being the most effective treatment. The limited availability of donor organs poses a challenge, leading to interest in kidney xenotransplantation. This approach has gained traction due to advances in gene editing, insights into rejection mechanisms, new immunosuppressive strategies, and the commencement of clinical research

Donor Bladder Inclusion in Kidney Transplantation

This review evaluates bladder inclusion as a reconstructive method in kidney transplantation, especially within pediatric en bloc kidney transplants. With appropriate patient selection, both partial and complete bladder transplants can be conducted safely. The technique is simple and offers a reliable approach for urinary reconstruction and donor ureteral implantation

Liver Transplant for Combined Hepatocellular-Cholangiocarcinoma

There is a lack of recent population-level data regarding liver transplantation for combined hepatocellular–cholangiocarcinoma and the effects of current allocation practices, particularly during the Median MELD at Transplant minus 3 policy era.

Less Invasive Acute Rejection Surveillance After Pediatric Heart Transplantation

Acute rejection is a significant contributor to morbidity and mortality in pediatric heart transplantation. Current guidelines suggest that endomyocardial biopsies are the only reliable method for rejection surveillance. This study aimed to investigate the clinical outcomes of implementing less invasive rejection surveillance methods at a low-intensity biopsy center for pediatric heart recipients.

Association Between Solid Organ Transplantation and Oral Candidiasis

Oral candidiasis is linked to solid organ transplantation, as evidenced by various case-control and cohort studies.

New Drug Protects Liver After Intestinal Surgery and Boosts Nutrient Absorption

A risky but often lifesaving surgery that removes damaged parts of the small intestine can leave patients facing a new threat: serious liver damage with no available treatment. Now, scientists have developed a promising compound that works directly in the gut to shield the liver and improve how the body absorbs nutrients. In mouse studies, the drug boosted weight gain, reduced harmful liver scarring and avoided side effects by staying confined to the intestines.

NEWS

Current Status of Kidney Xenotransplantation in Basic Research

Donor Bladder Inclusion in Kidney Transplantation

Liver Transplant for Combined Hepatocellular-Cholangiocarcinoma

Less Invasive Acute Rejection Surveillance After Pediatric Heart Transplantation

Association Between Solid Organ Transplantation and Oral Candidiasis

New Drug Protects Liver After Intestinal Surgery and Boosts Nutrient Absorption

Comparative Analysis of Kidney and Simultaneous Pancreas Kidney Transplantation

Association of Pre-Transplant Torque Teno Virus Load With Early Post-Transplant Outcomes in Lung Transplant Recipients

Post-Transplant Tremor: Characteristics and Differences Based on Sex and Post-Transplant Therapy

Association of Azathioprine and Nonmelanoma Skin Cancer Risks for Organ Donor Recipients